Find a Clinical Trial

A Phase 3 Study of Sotatercept in Participants with PAH WHO FC III or FC IV at High Risk of Mortality

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sotatercept When Added to Maximum Tolerated Background Therapy in Participants With Pulmonary Arterial Hypertension (PAH) World Health Organization (WHO) Functional Class (FC) III or FC IV at High Risk of Mortality

18-75

Learn more

SUMMIT MAX

A Prospective, Randomized, Controlled, Interventional Clinical Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical MonoPoint® Reperfusion System for Aspiration Embolectomy in Acute Ischemic Stroke Patients

18-85

Learn more

AbbVie EAISE

A Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Study to Assess the Safety and Efficacy of Elezanumab in Acute Ischemic Stroke

30-80

Learn more

TETON-PPF

A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Progressive Pulmonary Fibrosis (TETON-PPF)

18-100

Learn more

Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis

40+

Learn more

Keros PAH Study

A Randomized, Phase 2, Double-blind, Placebo-controlled Study to
Investigate the Safety and Efficacy of KER-012 in Combination with
Background Therapy in Adult Participants with Pulmonary Arterial
Hypertension (TROPOS Study)

18-100

Learn more

Pivotal Evaluation of Abdominal Neuromuscular Electrical Stimulation for Weaning from Mechanical Ventilation (PREVENT)

A Randomized, Sham Controlled, Doubleblinded, Multi-center Trial to Evaluate the
Efficacy of the VentFree Respiratory Muscle Stimulator to Assist Ventilator Weaning in Critically Ill Patients

22+

Learn more

PFO-PAS

Amplatzer PFO Occluder Post Approval Study (PFO PAS)

18-60

Learn more

Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-OLE)

An Open-label Extension Study of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis

40-99

Learn more

A Long-term Follow-up Study of Sotatercept for PAH Treatment

An Open-Label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH

18+

Learn more